Semaglutide (brand names Ozempic, Wegovy, Rybelsus) and Tirzepatide (brand names Mounjaro, Zepbound) are injectable medications that help regulate blood sugar and reduce appetite by mimicking certain hormones involved in glucose regulation and digestion
GLP-1 receptor agonists slow down how quickly your stomach empties
Main Points to Remember Here are the highlights to consider when comparing these medications: Tirzepatide leads to more significant weight loss results , with nearly half of users achieving over 20% weight loss and more than 80% losing at least 5% of their body weight
Movement Snail movement ranged from 0.02 cm/s to 0.07 cm/s after 14 days of treatment exposure (Figure 2
in the Journal of Clinical Endocrinology and Metabolism (2006)
Oral GLP-1 medicines are available for weight management, including orforglipron (Foundayo), approved by the FDA in April 2026, and an oral form of semaglutide